Influence of age on the efficacy and safety of vardenafil, a novel phosphodiesterase-5 inhibitor, for the treatment of erectile dysfunction.

被引：0
|
作者：
Donatucci, C
Karlin, G
Goldfischer, E
Cohen, S
Thibonnier, M
机构：
[1] Duke Univ, Med Ctr, Div Urol, Durham, NC USA
[2] Lawrenceville Urol, Lawrenceville, NJ USA
[3] Hudson Valley Urol Ctr, Poughkeepsie, NY USA
[4] Clin Res Consultants, Trumbull, CT USA
[5] Bayer Corp, West Haven, CT USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2002年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P293
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [1] Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction
    Reffelmann, Thorsten
    Kloner, Robert A.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (07) : 965 - 974
  • [2] Vardenafil -: Treatment of erectile dysfunction -: Phosphodiesterase 5 inhibitor
    Sorbera, LA
    Martin, L
    Rabasseda, X
    Castañer, J
    [J]. DRUGS OF THE FUTURE, 2001, 26 (02) : 141 - 144
  • [3] Vardenafil - An oral selective phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction
    Coleman, CI
    Carabino, JM
    Vergara, CM
    Wang, F
    [J]. FORMULARY, 2003, 38 (03) : 131 - +
  • [4] Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 diabetic patients with erectile dysfunction
    Ziegler, D
    Merfort, F
    Van Ahlen, H
    Reblin, T
    Neureither, M
    [J]. DIABETES, 2005, 54 : A127 - A127
  • [5] Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
    Padma-Nathan, H
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (9A): : 19M - 25M
  • [6] Safety and efficacy of intraurethral alprostadil in patients with erectile dysfunction refractory to treatment using phosphodiesterase-5 inhibitors
    Garrido Abad, P.
    Sinues Ojas, B.
    Martinez Blazquez, L.
    Conde Caturla, P.
    Fernandez Arjona, M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2015, 39 (10): : 635 - 640
  • [7] Efficacy and safety of the phosphodiesterase type-5 inhibitor vardenafil in men with erectile dysfunction and type 1 diabetes mellitus
    Van, Hermann Ahlen
    Merfort, Frank
    Reblin, Tjark
    Neureither, Marcus
    [J]. DIABETES, 2006, 55 : A103 - A104
  • [8] Managing Erectile Dysfunction in Patients With Cardiovascular Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors
    Cheng, Judy W. M.
    Berhane, Selamawit R.
    [J]. AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2009, 3 (03) : 201 - 211
  • [9] Efficacy and safety of vardenafil in patients with erectile dysfunction.: Results of the Mexican multicentric study
    Sotomayor-de-Zavaleta, M
    Rubio-Aurioles, E
    Feria-Bernal, G
    Mendoza-Valdés, A
    Quinzaños-Sordo, LF
    Ugarte-y-Romano, F
    Hurtado-Coll, A
    Telich-Vidal, M
    Barreto-Fernández, MA
    Tapia-Serrano, MD
    Ureta-Sánchez, SE
    Jaspersen-Gastelum, J
    Pacheco-Gahbler, C
    Sentíes-Hernández, IR
    Olguin, J
    Pérez-García, J
    [J]. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2004, 56 (05): : 572 - 579
  • [10] The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus
    Radovits, T.
    Boemicke, T.
    Koekeny, G.
    Arif, R.
    Loganathan, S.
    Kecsan, K.
    Korkmaz, S.
    Barnucz, E.
    Sandner, P.
    Karck, M.
    Szabo, G.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 156 (06) : 909 - 919
12345